Search Results
Article
FDA guidance on selecting, developing, or modifying fit-for-purpose clinical outcome assessments: Old wine in a new bottle?
January 01, 2023
Article
Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviews
December 01, 2022
Article
ABCL-310 Health-related quality of life and tolerability in patients with/without skin toxicity during loncastuximab tesirine treatment in a phase 2 clinical trial (LOTIS-2)
October 01, 2022
Article
A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014-2018)
September 01, 2022
Article
Ethical considerations for the inclusion of patient-reported outcomes in clinical research: The PRO ethics guidelines
May 17, 2022
Article
A review of patient-reported outcome labeling of FDA-approved new drugs (2016-2020): Counts, categories, and comprehensibility
April 01, 2022
Article
Health-related quality of life, symptoms, and tolerability of loncastuximab tesirine in patients with relapsed or refractory diffuse large B-cell lymphoma
March 01, 2022
Article
Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiency
February 05, 2022